NeuroMetrix (NURO)
(Delayed Data from NSDQ)
$4.10 USD
+0.21 (5.40%)
Updated Sep 25, 2024 03:51 PM ET
After-Market: $3.94 -0.16 (-3.90%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for NeuroMetrix, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 6 | 8 | 8 | 7 | 9 |
Cost Of Goods | 2 | 3 | 2 | 2 | 7 |
Gross Profit | 4 | 6 | 6 | 5 | 2 |
Selling & Adminstrative & Depr. & Amort Expenses | 11 | 10 | 8 | 7 | 14 |
Income After Depreciation & Amortization | -7 | -5 | -2 | -2 | -12 |
Non-Operating Income | 1 | 0 | 0 | 0 | 8 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -7 | -4 | -2 | -2 | -4 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -7 | -4 | -2 | -2 | -4 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -7 | -4 | -2 | -2 | -4 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -7 | -5 | -2 | -2 | -11 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -7 | -5 | -2 | -2 | -12 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 1.04 | 0.89 | 0.63 | 0.38 | 0.12 |
Diluted EPS Before Non-Recurring Items | -6.27 | -4.96 | -3.60 | -5.52 | -31.20 |
Diluted Net EPS (GAAP) | -6.27 | -4.96 | -3.60 | -5.52 | -31.20 |
Fiscal Year end for NeuroMetrix, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.77 | 1.09 | 1.32 | 1.20 | 1.66 |
Cost Of Goods | 0.28 | 0.58 | 0.47 | 0.42 | 0.54 |
Gross Profit | 0.49 | 0.52 | 0.85 | 0.78 | 1.12 |
SG&A, R&D, and Dept/Amort Expenses | 2.32 | 3.77 | 2.70 | 2.74 | 2.74 |
Income After SG&A, R&D, and Dept/Amort Expenses | -1.83 | -3.25 | -1.85 | -1.96 | -1.62 |
Non-Operating Income | 0.34 | 0.22 | 0.21 | 0.19 | 0.09 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -1.49 | -3.03 | -1.65 | -1.77 | -1.54 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -1.49 | -3.03 | -1.65 | -1.77 | -1.54 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -1.49 | -3.03 | -1.65 | -1.77 | -1.54 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 2.01 | 1.81 | 1.15 | 1.05 | 1.01 |
Diluted EPS Before Non-Recurring Items | -0.74 | -1.67 | -1.43 | -1.68 | -1.52 |
Diluted Net EPS (GAAP) | -0.74 | -1.67 | -1.47 | -1.68 | -1.52 |